Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) SHH

10.88

+0.05(+0.46%)

Updated at September 30 10:40AM

Currency In CNY

Valuation

Market Cap3.56B
Enterprise Value4.93B
P/E Ratio-120.81
PEG Ratio-13.29
Price/Sales Ratio1.96
Price/Book Ratio1.97
Enterprise/Revenue2.73
Enterprise/EBITDA144.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.02
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue2.35B
Revenue/Share5.06
Gross Profit456.73M
EBITDA261.16M
Net Income-49.1M
Diluted EPS-0.12

Balance Sheet

Total Cash433.05M
Total Cash/Share0.91
Total Debt2.29B
Total Debt/Equity0.87
Current Ratio0.89
Book Value Per Share5.51

Price History

52-Week Change11.88
52-Week High12.82
52-Week Low7.44
Moving Average 50 Days11.38
Moving Average 200 Days9.54

Statistics

Average Volume15.23M
Shares Outstanding438.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield1.39
Payout Ratio-3.85
Last Split Factor7:5
Last Split DateJune 17, 2022